{"id":"https://openalex.org/W3048679999","doi":"https://doi.org/10.1001/jamacardio.2020.3151","title":"Efficacy and Safety of PCSK9 Inhibition With Evolocumab in Reducing Cardiovascular Events in Patients With Metabolic Syndrome Receiving Statin Therapy: Secondary Analysis From the FOURIER Randomized Clinical Trial","display_name":"Efficacy and Safety of PCSK9 Inhibition With Evolocumab in Reducing Cardiovascular Events in Patients With Metabolic Syndrome Receiving Statin Therapy: Secondary Analysis From the FOURIER Randomized Clinical Trial","alternate_titles":[],"publication_year":2020,"publication_date":"2020-08-13","ids":{"openalex":"https://openalex.org/W3048679999","doi":"https://doi.org/10.1001/jamacardio.2020.3151","mag":"3048679999","pmid":"https://pubmed.ncbi.nlm.nih.gov/32785614","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9426725"},"language":"en","primary_location":{"id":"doi:10.1001/jamacardio.2020.3151","doi":"https://doi.org/10.1001/jamacardio.2020.3151","is_oa":true,"landing_page_url":"https://doi.org/10.1001/jamacardio.2020.3151","pdf_url":"https://jamanetwork.com/journals/jamacardiology/articlepdf/2769181/jamacardiology_deedwania_2020_oi_200053_1612387615.45296.pdf","source":{"id":"https://openalex.org/S2765015654","display_name":"JAMA Cardiology","issn_l":"2380-6583","issn":["2380-6583","2380-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Cardiology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3048679999"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://jamanetwork.com/journals/jamacardiology/articlepdf/2769181/jamacardiology_deedwania_2020_oi_200053_1612387615.45296.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078294568","display_name":"PRAKASH C. DEEDWANIA","orcid":"https://orcid.org/0000-0002-5652-9347","observed_orcids":["https://orcid.org/0000-0002-5652-9347"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Prakash Deedwania","raw_affiliation_strings":["University of California School of Medicine, San Francisco, Fresno"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California School of Medicine, San Francisco, Fresno","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085897222","display_name":"Sabina A. Murphy","orcid":"https://orcid.org/0000-0002-8231-3611","observed_orcids":["https://orcid.org/0000-0002-8231-3611"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210159766","display_name":"Thrombolysis in Myocardial Infarction Study Group","ror":"https://ror.org/05vp7ha71","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210159766"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sabina A. Murphy","raw_affiliation_strings":["TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210159766"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039563874","display_name":"Andr\u00e9 Jacques Scheen","orcid":"https://orcid.org/0000-0001-9743-4371","observed_orcids":["https://orcid.org/0000-0001-9743-4371"]},"institutions":[{"id":"https://openalex.org/I157674565","display_name":"University of Li\u00e8ge","ror":"https://ror.org/00afp2z80","country_code":"BE","type":"education","lineage":["https://openalex.org/I157674565"]},{"id":"https://openalex.org/I4210134544","display_name":"Centre Hospitalier Universitaire de Li\u00e8ge","ror":"https://ror.org/044s61914","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210134544"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andre Scheen","raw_affiliation_strings":["Department of Medicine, CHU Li\u00e8ge, Li\u00e8ge University, Li\u00e8ge, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, CHU Li\u00e8ge, Li\u00e8ge University, Li\u00e8ge, Belgium","institution_ids":["https://openalex.org/I157674565","https://openalex.org/I4210134544"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084636551","display_name":"Jolita Badarien\u0117","orcid":"https://orcid.org/0000-0003-1184-9803","observed_orcids":["https://orcid.org/0000-0003-1184-9803"]},"institutions":[{"id":"https://openalex.org/I173212132","display_name":"Vilnius University","ror":"https://ror.org/03nadee84","country_code":"LT","type":"education","lineage":["https://openalex.org/I173212132"]}],"countries":["LT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jolita Badariene","raw_affiliation_strings":["Clinic of Cardiac and Vascular Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinic of Cardiac and Vascular Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania","institution_ids":["https://openalex.org/I173212132"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022099697","display_name":"Armando Lira Pineda","orcid":"https://orcid.org/0000-0002-1746-3162","observed_orcids":["https://orcid.org/0000-0002-1746-3162"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Armando Lira Pineda","raw_affiliation_strings":["Amgen, Thousand Oaks, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, Thousand Oaks, California","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032281288","display_name":"Narimon Honarpour","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Narimon Honarpour","raw_affiliation_strings":["Amgen, Thousand Oaks, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, Thousand Oaks, California","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011948462","display_name":"ANTHONY C. KEECH","orcid":"https://orcid.org/0000-0002-9426-9136","observed_orcids":["https://orcid.org/0000-0002-9426-9136"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I42131985","display_name":"National Health and Medical Research Council","ror":"https://ror.org/011kf5r70","country_code":"AU","type":"government","lineage":["https://openalex.org/I2801453606","https://openalex.org/I3149551504","https://openalex.org/I42131985"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anthony C. Keech","raw_affiliation_strings":["Sydney Medical School, NHMRC Clinical Trials Centre, University of Sydney, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sydney Medical School, NHMRC Clinical Trials Centre, University of Sydney, Australia","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I42131985"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111847356","display_name":"Peter Sever","orcid":"https://orcid.org/0000-0003-0421-2409","observed_orcids":["https://orcid.org/0000-0003-0421-2409"]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter S. Sever","raw_affiliation_strings":["National Heart and Lung Institute, Imperial College London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Heart and Lung Institute, Imperial College London, United Kingdom","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111756488","display_name":"Terje Rolf Pedersen","orcid":"https://orcid.org/0000-0003-3975-5390","observed_orcids":["https://orcid.org/0000-0003-3975-5390"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]},{"id":"https://openalex.org/I184942183","display_name":"University of Oslo","ror":"https://ror.org/01xtthb56","country_code":"NO","type":"education","lineage":["https://openalex.org/I184942183"]}],"countries":["NO"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Terje R. Pedersen","raw_affiliation_strings":["Oslo University Hospital, Ullev\u00e5l and Medical Faculty, University of Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oslo University Hospital, Ullev\u00e5l and Medical Faculty, University of Oslo, Norway","institution_ids":["https://openalex.org/I1281400175","https://openalex.org/I184942183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030057930","display_name":"Marc Steven Sabatine","orcid":"https://orcid.org/0000-0002-0691-3359","observed_orcids":["https://orcid.org/0000-0002-0691-3359"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210159766","display_name":"Thrombolysis in Myocardial Infarction Study Group","ror":"https://ror.org/05vp7ha71","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210159766"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marc S. Sabatine","raw_affiliation_strings":["Deputy Editor, JAMA Cardiology","TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Deputy Editor, JAMA Cardiology","institution_ids":[]},{"raw_affiliation_string":"TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210159766"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045665978","display_name":"Robert Patrick Giugliano","orcid":"https://orcid.org/0000-0003-4110-7675","observed_orcids":["https://orcid.org/0000-0003-4110-7675"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210159766","display_name":"Thrombolysis in Myocardial Infarction Study Group","ror":"https://ror.org/05vp7ha71","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210159766"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert P. Giugliano","raw_affiliation_strings":["TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210159766"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":13,"corresponding_author_ids":["https://openalex.org/A5078294568"],"corresponding_institution_ids":["https://openalex.org/I180670191"],"apc_list":null,"apc_paid":null,"fwci":7.6039,"has_fulltext":true,"cited_by_count":89,"citation_normalized_percentile":{"value":0.9829436,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"6","issue":"2","first_page":"139","last_page":"139"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/evolocumab","display_name":"evolocumab","score":0.9800000190734863},{"id":"https://openalex.org/keywords/pcsk9-inhibition","display_name":"PCSK9 inhibition","score":0.8899999856948853},{"id":"https://openalex.org/keywords/metabolic-syndrome","display_name":"metabolic syndrome","score":0.9980000257492065},{"id":"https://openalex.org/keywords/statin-therapy","display_name":"statin therapy","score":0.9070000052452087},{"id":"https://openalex.org/keywords/cardiovascular-events","display_name":"cardiovascular events","score":0.7990000247955322},{"id":"https://openalex.org/keywords/fourier-trial","display_name":"FOURIER trial","score":0.7329999804496765},{"id":"https://openalex.org/keywords/ldl-cholesterol-lowering","display_name":"LDL cholesterol lowering","score":0.7799999713897705},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.46299999952316284},{"id":"https://openalex.org/keywords/cardiovascular-risk-stratification","display_name":"cardiovascular risk stratification","score":0.6980000138282776},{"id":"https://openalex.org/keywords/secondary-prevention","display_name":"secondary prevention","score":0.5149999856948853},{"id":"https://openalex.org/keywords/atherosclerotic-cardiovascular-disease","display_name":"atherosclerotic cardiovascular disease","score":0.8299999833106995},{"id":"https://openalex.org/keywords/cardiovascular-mortality","display_name":"cardiovascular mortality","score":0.3799999952316284},{"id":"https://openalex.org/keywords/myocardial-infarction","display_name":"myocardial infarction","score":0.9350000023841858},{"id":"https://openalex.org/keywords/stroke","display_name":"stroke","score":0.9570000171661377},{"id":"https://openalex.org/keywords/coronary-revascularization","display_name":"coronary revascularization","score":0.8050000071525574},{"id":"https://openalex.org/keywords/unstable-angina","display_name":"unstable angina","score":0.5870000123977661}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9648246765136719},{"id":"https://openalex.org/C2778114629","wikidata":"https://www.wikidata.org/wiki/Q15623825","display_name":"Evolocumab","level":5,"score":0.947772741317749},{"id":"https://openalex.org/C2780948078","wikidata":"https://www.wikidata.org/wiki/Q21130010","display_name":"PCSK9","level":5,"score":0.8596672415733337},{"id":"https://openalex.org/C2780902209","wikidata":"https://www.wikidata.org/wiki/Q4726914","display_name":"Alirocumab","level":5,"score":0.685261607170105},{"id":"https://openalex.org/C2780578515","wikidata":"https://www.wikidata.org/wiki/Q657193","display_name":"Metabolic syndrome","level":3,"score":0.6228613257408142},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.5685973167419434},{"id":"https://openalex.org/C2910980524","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","level":3,"score":0.48884886503219604},{"id":"https://openalex.org/C2776485726","wikidata":"https://www.wikidata.org/wiki/Q17141389","display_name":"Rescue therapy","level":2,"score":0.429910808801651},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4185096025466919},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.34415948390960693},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.33760884404182434},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.33369189500808716},{"id":"https://openalex.org/C43554185","wikidata":"https://www.wikidata.org/wiki/Q425649","display_name":"LDL receptor","level":4,"score":0.14117127656936646},{"id":"https://openalex.org/C62746215","wikidata":"https://www.wikidata.org/wiki/Q14890615","display_name":"Apolipoprotein B","level":3,"score":0.09640732407569885},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.07661482691764832},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.0},{"id":"https://openalex.org/C2780745583","wikidata":"https://www.wikidata.org/wiki/Q1316030","display_name":"Apolipoprotein A1","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000091362","descriptor_name":"PCSK9 Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000789","descriptor_name":"Angina, Unstable","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006760","descriptor_name":"Hospitalization","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009203","descriptor_name":"Myocardial Infarction","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D009204","descriptor_name":"Myocardial Revascularization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D020521","descriptor_name":"Stroke","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D024821","descriptor_name":"Metabolic Syndrome","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D024821","descriptor_name":"Metabolic Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D024821","descriptor_name":"Metabolic Syndrome","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1001/jamacardio.2020.3151","doi":"https://doi.org/10.1001/jamacardio.2020.3151","is_oa":true,"landing_page_url":"https://doi.org/10.1001/jamacardio.2020.3151","pdf_url":"https://jamanetwork.com/journals/jamacardiology/articlepdf/2769181/jamacardiology_deedwania_2020_oi_200053_1612387615.45296.pdf","source":{"id":"https://openalex.org/S2765015654","display_name":"JAMA Cardiology","issn_l":"2380-6583","issn":["2380-6583","2380-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Cardiology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9426725","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9426725/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Cardiol","raw_type":"Text"},{"id":"pmid:32785614","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32785614","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA cardiology","raw_type":"Journal Article"},{"id":"pmh:oai:orbi.ulg.ac.be:2268/250103","doi":null,"is_oa":false,"landing_page_url":"https://orbi.uliege.be/handle/2268/250103","pdf_url":null,"source":{"id":"https://openalex.org/S4306401300","display_name":"ORBi (University of Li\u00e8ge)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I157674565","host_organization_name":"University of Li\u00e8ge","host_organization_lineage":["https://openalex.org/I157674565"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"JAMA Cardiology (2021)","raw_type":"http://purl.org/coar/resource_type/c_6501"}],"best_oa_location":{"id":"doi:10.1001/jamacardio.2020.3151","doi":"https://doi.org/10.1001/jamacardio.2020.3151","is_oa":true,"landing_page_url":"https://doi.org/10.1001/jamacardio.2020.3151","pdf_url":"https://jamanetwork.com/journals/jamacardiology/articlepdf/2769181/jamacardiology_deedwania_2020_oi_200053_1612387615.45296.pdf","source":{"id":"https://openalex.org/S2765015654","display_name":"JAMA Cardiology","issn_l":"2380-6583","issn":["2380-6583","2380-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Cardiology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320308347","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94"},{"id":"https://openalex.org/F4320314793","display_name":"Intarcia Therapeutics","ror":"https://ror.org/00s0pgz81"},{"id":"https://openalex.org/F4320315027","display_name":"Amarin Corporation","ror":"https://ror.org/02fccce66"},{"id":"https://openalex.org/F4320315666","display_name":"Medicines Company","ror":null},{"id":"https://openalex.org/F4320316238","display_name":"Kowa Company","ror":"https://ror.org/009z2z347"},{"id":"https://openalex.org/F4320316473","display_name":"Mylan","ror":"https://ror.org/04nsw4151"},{"id":"https://openalex.org/F4320319139","display_name":"Zora Biosciences","ror":"https://ror.org/00t2dw182"},{"id":"https://openalex.org/F4320320303","display_name":"Bayer HealthCare","ror":"https://ror.org/04hmn8g73"},{"id":"https://openalex.org/F4320322148","display_name":"Eisai","ror":"https://ror.org/04vvh7p27"},{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"},{"id":"https://openalex.org/F4320327235","display_name":"Servier","ror":"https://ror.org/034e7c066"},{"id":"https://openalex.org/F4320331660","display_name":"Esperion Therapeutics","ror":"https://ror.org/019f2k932"},{"id":"https://openalex.org/F4320338262","display_name":"Daiichi Sankyo Europe","ror":"https://ror.org/01qhj1g70"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3048679999.pdf","grobid_xml":"https://content.openalex.org/works/W3048679999.grobid-xml"},"referenced_works_count":24,"referenced_works":["https://openalex.org/W1579491283","https://openalex.org/W2001328643","https://openalex.org/W2054356183","https://openalex.org/W2069616685","https://openalex.org/W2076974496","https://openalex.org/W2097510503","https://openalex.org/W2103108681","https://openalex.org/W2103714496","https://openalex.org/W2114027342","https://openalex.org/W2115169717","https://openalex.org/W2143104968","https://openalex.org/W2210694332","https://openalex.org/W2486690983","https://openalex.org/W2509676484","https://openalex.org/W2546044729","https://openalex.org/W2596179513","https://openalex.org/W2596236174","https://openalex.org/W2748800769","https://openalex.org/W2754562397","https://openalex.org/W2899997727","https://openalex.org/W2900034165","https://openalex.org/W3031647128","https://openalex.org/W6729219972","https://openalex.org/W6756602680"],"related_works":["https://openalex.org/W2946347198","https://openalex.org/W3138750700","https://openalex.org/W2905777991","https://openalex.org/W2891455762","https://openalex.org/W4234176463","https://openalex.org/W2754562397","https://openalex.org/W2210694332","https://openalex.org/W2748261813","https://openalex.org/W3017084496","https://openalex.org/W2963654427"],"abstract_inverted_index":{"Importance:":[0],"The":[1,44,137,154],"PCSK9":[2],"inhibitor":[3],"evolocumab":[4,33,58,130,279,399],"reduced":[5,230,370],"low-density":[6,231,371],"lipoprotein":[7,232,372],"cholesterol":[8,233,373],"and":[9,37,42,121,135,217,252,285,291,314,349,356,374,409,413],"cardiovascular":[10,26,53,142,160,202,354,363,375,407,418],"events":[11,203,364],"in":[12,34,101,182,235,288,344,377,403],"the":[13,83,90,215,224,269,273,300,305,327,396],"FOURIER":[14,45],"randomized":[15,47,128],"clinical":[16],"trial.":[17],"Patients":[18,126,351],"with":[19,32,36,50,61,82,188,194,237,278,290,342,346,352,379,405],"metabolic":[20],"syndrome":[21],"(MetS)":[22],"are":[23],"at":[24,110,198],"increased":[25],"risk.":[27,419],"Objective:":[28],"To":[29],"investigate":[30],"outcomes":[31,336],"patients":[35,48,81,104,170,195,236,289,345,378,404],"without":[38,196,253,292,381],"MetS.":[39,347],"Design,":[40],"Setting,":[41],"Participants:":[43],"trial":[46],"worldwide":[49],"stable":[51],"atherosclerotic":[52,353,406],"disease":[54,355,408],"receiving":[55],"statin":[56,366,401],"to":[57,74,115,129,400,415],"vs":[59,245,261,280],"placebo":[60,281,343],"follow-up":[62],"for":[63,148,214,223,295,318],"a":[64],"median":[65],"of":[66,201,329,362,398],"2.2":[67],"years.":[68],"Data":[69],"were":[70,86,105,127,282,311],"collected":[71],"February":[72],"2013":[73],"November":[75],"2016.":[76],"For":[77,268,299],"this":[78,183],"prespecified":[79],"analysis,":[80,184],"requisite":[84],"data":[85,394],"stratified":[87],"based":[88],"on":[89],"National":[91],"Cholesterol":[92],"Education":[93],"Program":[94],"Adult":[95],"Treatment":[96],"Panel":[97],"III":[98],"MetS":[99,190,238,254,293,357,380,410],"criteria;":[100],"secondary":[102,156,226,302],"analyses,":[103],"further":[106],"substratified":[107],"by":[108],"diabetes":[109,331],"baseline.":[111],"Analysis":[112,117],"was":[113,141,159],"intention":[114],"treat.":[116],"began":[118],"March":[119],"2018":[120],"ended":[122],"April":[123],"2020.":[124],"Interventions:":[125],"or":[131,151,164,332,388],"placebo.":[132],"Main":[133],"Outcomes":[134],"Measures:":[136],"primary":[138,216,270],"end":[139,157,227,271,303],"point":[140,158],"death,":[143,161],"myocardial":[144,162],"infarction,":[145,163],"stroke,":[146],"hospitalization":[147],"unstable":[149],"angina,":[150],"coronary":[152],"revascularization.":[153],"key":[155,225,301],"stroke.":[165],"Results:":[166],"Of":[167],"27":[168],"342":[169],"(mean":[171],"[SD]":[172],"age,":[173],"63":[174],"[9]":[175],"years;":[176],"20":[177],"623":[178],"men":[179],"[75.4%])":[180],"included":[181],"16":[185],"361":[186],"(59.8%)":[187],"baseline":[189],"were,":[191],"when":[192],"compared":[193,341],"MetS,":[197],"higher":[199],"risk":[200,328,361,376],"(adjusted":[204],"hazard":[205,274,307],"ratio":[206],"[95%":[207],"CI],":[208],"1.31":[209],"[1.18-1.46];":[210],"P":[211,220,249,265],"<":[212,221,250,266],".001":[213,222],"1.38":[218],"[1.20-1.57];":[219],"point).":[228],"Evolocumab":[229,323,368],"similarly":[234],"(median":[239,255],"[interquartile":[240,256],"range],":[241,257],"92":[242,258],"[79-109]":[243],"mg/dL":[244,260],"30":[246],"[19-48]":[247],"mg/dL;":[248],".001)":[251],"[81-108]":[259],"29":[262],"[18-44]":[263],"mg/dl;":[264],".001).":[267],"point,":[272,304],"ratios":[275,308],"(95%":[276,309],"CI)":[277],"0.83":[283],"(0.76-0.91)":[284],"0.89":[286],"(0.79-1.01)":[287],"(P":[294,317],"interaction":[296,319],"=":[297,320],".39).":[298],"corresponding":[306],"CIs)":[310],"0.76":[312],"(0.68-0.86)":[313],"0.86":[315],"(0.74-1.01)":[316],".23),":[321],"respectively.":[322],"did":[324],"not":[325],"increase":[326],"new-onset":[330,383],"other":[333,389],"major":[334,390],"safety":[335,391],"including":[337],"worsening":[338,385],"glycemic":[339,386],"control,":[340,387],"Conclusions":[348],"Relevance:":[350],"have":[358],"substantial":[359],"residual":[360,417],"despite":[365],"therapy.":[367],"significantly":[369],"increasing":[382],"diabetes,":[384],"events.":[392],"These":[393],"suggest":[395],"addition":[397],"therapy":[402],"is":[411],"safe":[412],"efficacious":[414],"reduce":[416],"Trial":[420],"Registration:":[421],"ClinicalTrials.gov":[422],"Identifier:":[423],"NCT01764633.":[424]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3048679999","counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":17},{"year":2024,"cited_by_count":16},{"year":2023,"cited_by_count":21},{"year":2022,"cited_by_count":14},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2020-08-18T00:00:00"}
